[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

2019 Pseudomonas Infections Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pseudomonas Infections Ongoing Clinical Trials Study” analyzes the current scenario of all active Pseudomonas Infections trials across the world. The report presents ...

February 2019 62 pages

2019 Psoriasis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Psoriasis Ongoing Clinical Trials Study” analyzes the current scenario of all active Psoriasis trials across the world. The report presents top level analysis ...

February 2019 285 pages

2019 Psoriasis Vulgaris Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Psoriasis Vulgaris Ongoing Clinical Trials Study” analyzes the current scenario of all active Psoriasis Vulgaris trials across the world. The report presents ...

February 2019 209 pages

2019 Psoriatic Arthritis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Psoriatic Arthritis Ongoing Clinical Trials Study” analyzes the current scenario of all active Psoriatic Arthritis trials across the world. The report presents ...

February 2019 146 pages

2019 Psychosis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Psychosis Ongoing Clinical Trials Study” analyzes the current scenario of all active Psychosis trials across the world. The report presents top level analysis ...

February 2019 101 pages

2019 Psychotic Major Depression Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Psychotic Major Depression Ongoing Clinical Trials Study” analyzes the current scenario of all active Psychotic Major Depression trials across the world. The report ...

February 2019 34 pages

2019 Pterygium Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pterygium Ongoing Clinical Trials Study” analyzes the current scenario of all active Pterygium trials across the world. The report presents top level analysis ...

February 2019 44 pages

2019 Pulmonary Arterial Hypertension Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Pulmonary Arterial Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Arterial Hypertension trials across the world. The report ...

February 2019 151 pages

2019 Pulmonary Edema Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pulmonary Edema Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Edema trials ... for administering Pulmonary Edema patients are identified The report includes panorama of ongoing Pulmonary Edema clinical trials across ...

February 2019 41 pages

2019 Pulmonary Embolism Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pulmonary Embolism Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Embolism trials across the world. The report presents ...

February 2019 111 pages

2019 Pulmonary Fibrosis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pulmonary Fibrosis Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Fibrosis trials across the world. The report presents ...

February 2019 118 pages

2019 Pulmonary Hypertension Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pulmonary Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Hypertension trials across the world. The report presents ...

February 2019 219 pages

2019 Pulmonary Inflammation Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pulmonary Inflammation Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Inflammation trials across the world. The report presents ...

February 2019 35 pages

2019 Pulmonary Tuberculosis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pulmonary Tuberculosis Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Tuberculosis trials across the world. The report presents ...

February 2019 99 pages

2019 Pyelonephritis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Pyelonephritis Ongoing Clinical Trials Study” analyzes the current scenario of all active Pyelonephritis trials across the world. The report presents top level analysis ...

February 2019 53 pages

2019 Quadriplegia/Tetraplegia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... - “2019 Quadriplegia / Tetraplegia Ongoing Clinical Trials Study” analyzes the current scenario of all active Quadriplegia / Tetraplegia trials across the world. The report presents top level analysis of global Quadriplegia / Tetraplegia clinical trials across ...

February 2019 38 pages

2019 Rabies Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Rabies Ongoing Clinical Trials Study” analyzes the current scenario of all active Rabies trials across the world. The report presents top level analysis ...

February 2019 49 pages

2019 Radiation Induced Nausea and Vomiting (RINV) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... research report- “2019 Radiation Induced Nausea and Vomiting (RINV) Ongoing Clinical Trials Study” analyzes the current scenario of all active Radiation Induced Nausea and Vomiting (RINV ...

February 2019 33 pages

2019 Radiculopathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Radiculopathy Ongoing Clinical Trials Study” analyzes the current scenario of all active Radiculopathy trials across the world. The report presents top level analysis ...

February 2019 45 pages

2019 Radiodermatitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Radiodermatitis Ongoing Clinical Trials Study” analyzes the current scenario of all active Radiodermatitis trials across the world. The report presents top level analysis ...

February 2019 50 pages

2019 Ragweed Pollen Allergy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Ragweed Pollen Allergy Ongoing Clinical Trials Study” analyzes the current scenario of all active Ragweed Pollen Allergy trials across the world. The report ...

February 2019 36 pages

2019 Raynauds Disease Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Raynauds Disease Ongoing Clinical Trials Study” analyzes the current scenario of all active Raynauds Disease trials ... for administering Raynauds Disease patients are identified The report includes panorama of ongoing Raynauds Disease clinical trials across ...

February 2019 39 pages

2019 Recurrent Abortion Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Recurrent Abortion Ongoing Clinical Trials Study” analyzes the current scenario of all active Recurrent Abortion trials across the world. The report presents ...

February 2019 48 pages

2019 Recurrent Glioblastoma Multiforme (GBM) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... clinical trial research report- “2019 Recurrent Glioblastoma Multiforme (GBM) Ongoing Clinical Trials Study” analyzes the current scenario of all active Recurrent Glioblastoma Multiforme (GBM) trials across the world ...

February 2019 181 pages

2019 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... report- “2019 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Recurrent Head And Neck Cancer ...

February 2019 116 pages

2019 Recurrent Malignant Glioma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Recurrent Malignant Glioma Ongoing Clinical Trials Study” analyzes the current scenario of all active Recurrent Malignant Glioma trials across the world. The report ...

February 2019 61 pages

2019 Recurrent Medulloblastoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Recurrent Medulloblastoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Recurrent Medulloblastoma trials across the world. The report presents ...

February 2019 48 pages

2019 Reflux Esophagitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Reflux Esophagitis Ongoing Clinical Trials Study” analyzes the current scenario of all active Reflux Esophagitis trials across the world. The report presents ...

February 2019 159 pages

2019 Refractory Acute Myeloid Leukemia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... clinical trial research report- “2019 Refractory Acute Myeloid Leukemia Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Acute Myeloid Leukemia trials across the world ...

February 2019 289 pages

2019 Refractory Anemia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Refractory Anemia Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Anemia trials across the world. The report presents ...

February 2019 98 pages

2019 Refractory Anemia With Excess Blasts Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Refractory Anemia With Excess Blasts Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Anemia With Excess Blasts trials across the ...

February 2019 86 pages

2019 Refractory Anemia With Ringed Sideroblasts Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Refractory Anemia With Ringed Sideroblasts Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Anemia With Ringed Sideroblasts trials across the ...

February 2019 43 pages

2019 Refractory Angina Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Refractory Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Angina trials across the world. The report presents ...

February 2019 36 pages

2019 Refractory Chronic Lymphocytic Leukemia (CLL) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... clinical trial research report- “2019 Refractory Chronic Lymphocytic Leukemia (CLL) Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Chronic Lymphocytic Leukemia (CLL) trials across ...

February 2019 163 pages

2019 Refractory Leukemia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Refractory Leukemia Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Leukemia trials across the world. The report presents ...

February 2019 53 pages

2019 Refractory Multiple Myeloma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Refractory Multiple Myeloma Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Multiple Myeloma trials across the world. The report ...

February 2019 372 pages

2019 Regional Enteritis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Regional Enteritis Ongoing Clinical Trials Study” analyzes the current scenario of all active Regional Enteritis trials across the world. The report presents ...

February 2019 298 pages

2019 Regurgitation Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Regurgitation Ongoing Clinical Trials Study” analyzes the current scenario of all active Regurgitation trials across the world. The report presents top level analysis ...

February 2019 34 pages

2019 Relapsed Acute Myeloid Leukemia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... clinical trial research report- “2019 Relapsed Acute Myeloid Leukemia Ongoing Clinical Trials Study” analyzes the current scenario of all active Relapsed Acute Myeloid Leukemia trials across the world ...

February 2019 293 pages

2019 Relapsed Chronic Lymphocytic Leukemia (CLL) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... clinical trial research report- “2019 Relapsed Chronic Lymphocytic Leukemia (CLL) Ongoing Clinical Trials Study” analyzes the current scenario of all active Relapsed Chronic Lymphocytic Leukemia (CLL) trials across ...

February 2019 157 pages

2019 Relapsed Multiple Myeloma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Relapsed Multiple Myeloma Ongoing Clinical Trials Study” analyzes the current scenario of all active Relapsed Multiple Myeloma trials across the world. The report ...

February 2019 373 pages

2019 Relapsing Multiple Sclerosis (RMS) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... clinical trial research report- “2019 Relapsing Multiple Sclerosis (RMS) Ongoing Clinical Trials Study” analyzes the current scenario of all active Relapsing Multiple Sclerosis (RMS) trials across the world ...

February 2019 100 pages

2019 Relapsing Remitting Multiple Sclerosis (RRMS) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... clinical trial research report- “2019 Relapsing Remitting Multiple Sclerosis (RRMS) Ongoing Clinical Trials Study” analyzes the current scenario of all active Relapsing Remitting Multiple Sclerosis (RRMS) trials across ...

February 2019 189 pages

2019 Renal Anemia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Renal Anemia Ongoing Clinical Trials Study” analyzes the current scenario of all active Renal Anemia trials across ... researched for administering Renal Anemia patients are identified The report includes panorama of ongoing Renal Anemia clinical trials across the ...

February 2019 114 pages

2019 Renal Artery Stenosis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Renal Artery Stenosis Ongoing Clinical Trials Study” analyzes the current scenario of all active Renal Artery Stenosis trials across the world. The report ...

February 2019 34 pages

2019 Renal Cell Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Renal Cell Carcinoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Renal Cell Carcinoma trials across the world. The report ...

February 2019 426 pages

2019 Renal Colic Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Renal Colic Ongoing Clinical Trials Study” analyzes the current scenario of all active Renal Colic trials across the ... researched for administering Renal Colic patients are identified The report includes panorama of ongoing Renal Colic clinical trials across the ...

February 2019 42 pages

2019 Renal Insufficiency Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Renal Insufficiency Ongoing Clinical Trials Study” analyzes the current scenario of all active Renal Insufficiency trials across the world. The report presents ...

February 2019 100 pages

2019 Renal Pain Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Renal Pain Ongoing Clinical Trials Study” analyzes the current scenario of all active Renal Pain trials across the ... researched for administering Renal Pain patients are identified The report includes panorama of ongoing Renal Pain clinical trials across the ...

February 2019 43 pages

2019 Renal Stones Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Renal Stones Ongoing Clinical Trials Study” analyzes the current scenario of all active Renal Stones trials across ... researched for administering Renal Stones patients are identified The report includes panorama of ongoing Renal Stones clinical trials across the ...

February 2019 96 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers